This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Nmd Pharma A/s. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: The Innovations of Anders Riisager
Introduction
Anders Riisager is a notable inventor based in Skødstrup, Denmark. He has made significant contributions to the field of neuromuscular disorders through his innovative research and development of therapeutic compounds. His work is particularly focused on addressing the challenges associated with drug-induced neuromuscular blockade.
Latest Patents
Anders Riisager holds a patent for "Compounds for the treatment of neuromuscular disorders." This patent describes compounds that are suitable for treating, ameliorating, and preventing neuromuscular disorders. The compounds can inhibit the CIC-1 ion channel, which plays a crucial role in neuromuscular function. He has 1 patent to his name, showcasing his commitment to advancing medical science.
Career Highlights
Anders is currently associated with NMD Pharma A/S, a company dedicated to developing innovative treatments for neuromuscular diseases. His work at NMD Pharma A/S has positioned him as a key player in the pharmaceutical industry, particularly in the realm of neuromuscular research.
Collaborations
Anders has collaborated with notable colleagues, including Lars J S Knutsen and Nicholas Kelly. These partnerships have enhanced his research efforts and contributed to the development of effective treatments for neuromuscular disorders.
Conclusion
Anders Riisager's contributions to the field of neuromuscular disorders through his innovative compounds and collaborations highlight his importance as an inventor. His work continues to pave the way for advancements in medical treatments, ultimately benefiting patients worldwide.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile